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Summary
 
Using a murine respiratory challenge model we have previously demonstrated a role for Th1
cells in natural immunity against 
 
Bordetella pertussis
 
, but could not rule out a role for antibody.
Here we have demonstrated that 
 
B. pertussis
 
 respiratory infection of mice with targeted disrup-
tions of the genes for the IFN-
 
g
 
 receptor resulted in an atypical disseminated disease which was
lethal in a proportion of animals, and was characterized by pyogranulomatous inflammation
and postnecrotic scarring in the livers, mesenteric lymph nodes and kidneys. Viable virulent
bacteria were detected in the blood and livers of diseased animals. An examination of the
course of infection in the lung of IFN-
 
g
 
 receptor–deficient, IL-4–deficient and wild-type mice
demonstrated that lack of functional IFN-
 
g
 
 or IL-4, cytokines that are considered to play major
roles in regulating the development of Th1 and Th2 cells, respectively, did not affect the kinetics
of bacterial elimination from the lung. In contrast, B cell–deficient mice developed a persistent
infection and failed to clear the bacteria after aerosol inoculation. These findings demonstrate
an absolute requirement for B cells or their products in the resolution of a primary infection
with 
 
B. pertussis
 
, but also define a critical role for IFN-
 
g
 
 in containing bacteria to the mucosal
site of infection.
 
R
 
espiratory infection with the gram-negative coccoba-
cillus 
 
Bordetella pertussis
 
 results in whooping cough, a
major cause of morbidity and mortality in human infants. It
is well known that during colonization of the respiratory
tract this bacterium can specifically adhere to ciliated epi-
thelium, however a number of studies have suggested that
 
B. pertussis
 
 may also exploit an intracellular niche during
infection. Persistence of 
 
B. pertussis
 
 within murine and rab-
bit alveolar macrophages has been described (1, 2), and it has
recently been reported that 
 
B. pertussis
 
 can invade and sur-
vive within human macrophages (3–5). Although contro-
versial, these studies suggest that intracellular localization
may be an important mechanism in the disease process.
Recovery from a primary 
 
B. pertussis
 
 infection provides
long lasting protective immunity against subsequent dis-
ease, however it is not clear which components of the im-
mune response confer protection or contribute to bacterial
clearance. Passive and active immunization studies in mice
have shown that antibody can induce varying degrees of pro-
tection against either aerosol or intracerebral challenge (6,
7). In contrast, clinical trials of an acellular pertussis vaccine
consisting of chemically detoxified pertussis toxin (PT)
 
1
 
and filamentous hemagglutinin (FHA), failed to demon-
strate a correlation between serum antibody responses to
PT or FHA and protection (8). Furthermore, studies using
a murine respiratory infection model have demonstrated a
role for 
 
B. pertussis
 
–specific CD4
 
1
 
 T cells that secrete IL-2
and IFN-
 
g
 
 (Th1 cells) in pulmonary clearance (9–11).
Adoptive transfer experiments demonstrated that CD4
 
1
 
 T
cells from convalescent mice were capable of mediating 
 
B.
pertussis
 
 clearance from nude or sublethally irradiated mice
in the absence of a detectable serum antibody response (9).
However this study, as well as the results of passive immu-
nization experiments reported by others (6, 7, 12), did not
rule out a role for CD4
 
1
 
 T cells in providing help for a
protective antibody response against 
 
B. pertussis
 
.
The development of mouse strains with gene-targeted
disruptions in key components of the immune response has
provided insights into the mechanisms of antimicrobial de-
 
1
 
Abbreviations used in this paper:
 
 FHA, and filamentous hemagglutinin;
IFN-
 
g
 
R, IFN-
 
g
 
 receptor; PT, pertussis toxin.
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Bordetella pertussis
 
fense and pathology (13). Studies with gene knockout mice
have highlighted the central role of T cells in immunity
against the intracellular pathogens 
 
Listeria monocytogenes
 
 and
 
Mycobacterium tuberculosis
 
 (13, 14). In the present study we
have employed mice with targeted disruption of the genes
for IL-4 (IL-4
 
2/2
 
), the IFN-
 
g
 
 receptor (IFN-
 
g
 
R
 
2/2
 
), or
the immunoglobulin 
 
m
 
-chain (Ig
 
2/2
 
) to elucidate the role
of cytokines and the adaptive immune response to clear-
ance of a primary 
 
B. pertussis
 
 respiratory infection. We
demonstrate that in addition to the known requirement for
CD4
 
1
 
 T cells, clearance of this bacterium is dependent on
B cells. Studies addressing the contribution of different cy-
tokines demonstrated that functional IFN-
 
g
 
 or IL-4 were
not essential for bacterial clearance from the lungs, but re-
vealed that IFN-
 
g
 
 was critical in preventing bacterial dis-
semination.
 
Materials and Methods
 
Mice.
 
All mice used were commercially obtained (B
 
1
 
K Uni-
versal Ltd., Hull, UK) and bred and maintained according to the
guidelines of the Irish Department of Health. The IFN-
 
g
 
R
 
2/2
 
mice, in which IFN-
 
g
 
 is nonfunctional (15), were used with the
kind permission of Dr. M. Aguet (University of Zurich, Switzer-
land). These mice were generated from the wild-type 129Sv/Ev
(H-2
 
b
 
) strain (15), which were employed as the control mice in
these experiments. The IL-4
 
2/2
 
 mice (IL-4T strain) (16) were
used with the kind permission of Dr. Werner Muller (University
of Cologne, Germany), and the Ig
 
2/2
 
 (
 
m
 
MT strain) (17) were
used with the kind permission of Dr. Klaus Rajewsky (University
of Cologne, Germany). The Ig
 
2/2
 
 and IL-4
 
2/2
 
 mice, were gener-
ated from wild-type C57BL/6 ( H-2
 
b
 
) mice, which were em-
ployed as control mice in these experiments. Unless otherwise
stated, all mice were 8–12 wk old at the initiation of experiments.
 
Aerosol Infection.
 
Respiratory infection of mice was initiated
by aerosol challenge by a modification of the method described
by Sato et al. (18). Phase 1 
 
B. pertussis
 
 Wellcome 28 (W28; a kind
gift from Keith Redhead, National Institute for Biological Stan-
dards and Control, South Mimms, Herts, UK) was grown under
agitation conditions at 37
 
8
 
C in Stainer-Scholte liquid medium.
Bacteria from a 48-h culture were resuspended at a concentration
of 
 
z
 
2
 
 3 
 
10
 
10
 
 CFU/ml in physiological saline containing 1%
casein. The challenge inoculum was administered to mice as an
aerosol over a period of 15 min by means of a nebulizer as previ-
ously described (19). Groups of three or four mice were killed at
various times after aerosol challenge to assess the number of viable
 
B. pertussis
 
 in the lungs, livers, or peripheral blood.
 
Enumeration of Viable Bacteria.
 
Lungs or livers were removed
aseptically from infected mice and homogenized in 1 ml of sterile
physiological saline with 1% casein on ice. 100
 
 m
 
l of undiluted
homogenate or of serially diluted homogenate from individual
lungs or livers were spotted in triplicate onto Bordet-Gengou
agar plates and the number of CFU was estimated after 5 d of in-
cubation at 37
 
8
 
C. Results are reported as the mean viable 
 
B. per-
tussis
 
 for either individual lungs or livers from at least three mice
per time point per experimental group. The limit of detection
was 
 
z
 
log
 
10
 
 0.5 CFU per organ. In experiments on disseminating
infection, blood was aseptically sampled from a peripheral vein
and assessed for the presence of viable 
 
B. pertussis
 
. Samples of
whole blood or peripheral blood mononuclear cells, isolated by
metrizamide gradient centrifugation and lysis of red blood cells as
previously described (20), were plated on Bordet-Gengou agar
and the mean CFU/ml determined.
 
Bacterial Antigens.
 
Heat killed 
 
B. pertussis
 
 was prepared by in-
cubation of cells at 80
 
8
 
C for 30 min. Inactivation was confirmed by
demonstrating that bacteria could not be cultured from these prep-
arations. Genetically detoxified recombinant PT (PT-9K/129G),
native FHA and pertactin prepared from 
 
B. pertussis
 
 were kindly
provided by Rino Rappuoli (Chiron, Sienna, Italy). All antigen
preparations were of clinical grade, endotoxin free and produced
according to good manufacturing practice.
 
Analysis of B. pertussis-specific Antibody Production.
 
The levels of
serum antibody to 
 
B. pertussis
 
 were determined by ELISA using
 
B. pertussis
 
 sonicated extract (5 
 
m
 
g/ml) to coat the plates. Bound
antibodies were detected using alkaline phosphatase-conjugated
anti-mouse IgG (Sigma Chem. Co. Poole, Dorset, UK). Mouse
IgG subclasses were determined using alkaline phosphatase conju-
gated anti–mouse IgG1 (clone G1-65), IgG2a (clone R19-15),
IgG2b (R12-3), or IgG3 (R40-8L) purchased from PharMingen
(San Diego, CA). Antibody levels are expressed as the mean end-
point titers calculated by regression of the straight part of a curve
of OD vs. serum dilution to a cutoff of two standard deviations
above background control values.
 
T Cell Proliferation Assays.
 
Spleen cells from naive and in-
fected mice were resuspended at 2
 
 3 
 
10
 
6
 
/ml in RPMI-1640 me-
dium (Gibco, Paisley, UK) supplemented with 8% heat-inactivated
FCS (endotoxin content 0.071 ng/ml; Gibco), 100 U/ml penicil-
lin and 100 
 
m
 
g/ml streptomycin. Cells were cultured for 4 d with
heat killed
 
 B. pertussis
 
 (10
 
5
 
, 10
 
6
 
, or 10
 
7
 
/ml), heat-inactivated PT
(0.2–5.0 
 
m
 
g/ml), FHA (0.2–5.0 
 
m
 
g/ml), pertactin (0.2–5.0 
 
m
 
g/ml),
or medium alone and [
 
3
 
H]thymidine (0.5 
 
m
 
Ci/well; specific ac-
tivity 2.0 Ci/mmol) was added for the final 4 h of culture as de-
scribed (9). Results are given as the mean cpm of [
 
3
 
H]thymidine
incorporation for triplicate cultures for groups of at least three
mice, after subtraction of the background responses with medium
alone.
 
Analysis of Cytokine Production.
 
Spleen cells from infected mice
were cultured with 
 
B. pertussis
 
 antigens as described for the prolif-
eration assay. Supernatants were removed after 24 h to determine
IL-2 and after 72 h to determine IFN-
 
g
 
, IL-4, and IL-5 concen-
trations as previously described (9). In brief, IL-2 release was as-
sessed by testing the ability of culture supernatants to support the
proliferation of the IL-2–dependent cell line CTLL-2 and the
concentrations of murine IL-4, IL-5, and IFN-
 
g
 
 were determined
by immunoassay using commercially available antibodies (Phar-
Mingen). Concentrations were determined by comparing either
the proliferation or the OD for test samples with a standard curve
for recombinant cytokines of known potency and concentration.
 
Pathology.
 
Killed animals from 6 experiments (60 IFN-
 
g
 
R
 
2/2
 
,
28 Ig
 
2/2
 
, 28 IL-4
 
2/2
 
, 28 C57BL/6, and 54 129Sv/Ev mice) were
examined for signs of pathology. Furthermore in two separate
challenge experiments necropsies were specifically performed on
15 
 
B. pertussis
 
 infected IFN-
 
g
 
R
 
2/2
 
 mice, 4 wild-type 129Sv/Ev
mice and 4 uninfected IFN-
 
g
 
R
 
2/2 mice after euthanasia with
pentobarbitone sodium. Liver, lungs, spleens, kidneys, and brains
were placed in 10% neutral buffered formalin. After fixation, the
tissues were dehydrated and embedded in paraffin. Sections were
stained with hematoxylin and eosin (H & E) for histopathological
examination. For demonstration of B. pertussis antigen, paraffin
sections were stained using a commercial B. pertussis-specific anti-
serum (Difco Laboratories, Detroit, MI) at a dilution of 1/200 us-
ing an avidin-biotin technique (Vectastain Elite ABC; Vector
Laboratories, Burlingame, CA). Sections were counterstained with
hematoxylin.
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Results
Disseminating Infection in IFN-gR2/2 Mice after B. pertussis
Respiratory Challenge. Respiratory infection with B. per-
tussis proved lethal in a number of IFN-gR2/2 mice, par-
ticularly in mice younger than 8 wk and those that received
a high challenge inoculum (Fig. 1 and data not shown).
Death appeared to result from organ failure associated with
disseminating disease; B. pertussis infected IFN-gR2/2 mice
showed abnormal pathology not observed in the wild-type
129Sv/Ev mice. Furthermore, IFN-gR2/2 mice that sur-
vived the challenge frequently showed overt lesions, visible
macroscopically, in the liver, lungs, kidneys, spleen, and
mesentery. All wild-type 129Sv/Ev mice (54 mice, 6 ex-
periments) challenged with the same inoculum of bacteria
survived the infection and lesions were confined to the
lungs. All Ig2/2 and IL-42/2 or C57BL/6 mice survived
more than 20 wk after B. pertussis challenge.
Examination of 60 B. pertussis–infected IFN-gR2/2 mice
killed between 7–100 d after challenge (6 experiments), re-
vealed evidence of gross pathological changes outside the
lungs in 80% of animals. The most common examination
features were multiple pale, firm nodules up to 10 mm in
diameter projecting above the capsular surface of the liver.
Similar nodular lesions were visible in the kidneys, spleens,
and mesentery, but these were smaller than those in the
livers. In two separate experiments histopathological exam-
ination was performed on 15 B. pertussis infected IFN-gR2/2
24 d after challenge and atypical liver pathology was ob-
served in 100% of animals. The histological appearance of the
lesions was of pyogranulomatous inflammation and postne-
crotic scarring. Aggregates of neutrophils and macrophages
adjoined the areas of necrosis and infiltrates of lymphocytes
and plasma cells (Fig. 2, a and b). Fibroblastic proliferation
and collagenization were prominent particularly in the liv-
ers. Localized infiltrates of neutrophils, macrophages and
lymphoid cells observed in the brains of a minority of sur-
viving IFN-gR2/2 mice were largely confined to the lep-
tomeninges (Fig. 2 c and data not shown).
In addition to areas of pyogranulomatous inflammation,
infiltrates of macrophages and neutrophils were present in the
alveolar septae and lumens of the lungs. Areas of consolida-
tion were common in the lungs of each of 15 B. pertussis
infected IFN-gR2/2 mice examined. Granular deposits of
basophilic debris observed in the alveoli and bronchioles
correlated with the distribution of B. pertussis antigen (Fig.
2, d and e). Deposits of B. pertussis antigen were also evi-
dent in macrophages in areas of pyogranulomatous inflam-
mation in mesenteric lymph nodes (Fig. 2 f ).
Carriage of B. pertussis to secondary non pulmonary foci
was via the blood (Table 1). Viable bacteria could be re-
covered from the blood of aerosol infected IFN-gR2/2
mice between days 3 and 11, and from the liver between
days 7 and 56 after challenge, but viable bacteria could not
be cultured from sites outside the lung beyond day 56.
Analysis of the CFU counts from fractionated blood sam-
ples demonstrated that viable B. pertussis were associated
with the mononuclear cell fraction (data not shown). No
evidence of bacterial dissemination was observed in B. per-
tussis infected Ig2/2 and IL-42/2 or C57BL/6 mice (Table
I) and all animals survived the challenge. Furthermore,
there was no evidence of pathological changes in uninfected
IFN-gR2/2 mice or outside the lungs of B. pertussis infected
129Sv/Ev, IL-42/2, Ig2/2 or C57BL/6 mice. A minority of
B. pertussis infected Ig2/2 mice (3/28) displayed lung con-
solidation and granulomas, limited to a single lobe.
Clearance of B. pertussis from the Lungs of Gene Knockout
Mice. To examine the role of Th1 and Th2 cytokines on
the course of infection in the lungs, the kinetics of bacterial
clearance was monitored by performing CFU counts on
the lungs of wild-type and gene disrupted mice at intervals
after challenge. Although IFN-gR2/2 mice displayed an
atypical disease which proved lethal in z30% of infected
mice, the kinetics of bacterial clearance from the lungs of
surviving animals was not significantly different from the
wild-type 129Sv/Ev mice (Fig. 3). There was no signifi-
cant difference in the kinetics of bacterial clearance from
the lungs of IL-42/2 and the wild-type C57BL/6 mice
(Fig. 3). We have previously reported that MHC and non-
MHC differences between mouse strains influence murine
survival in the B. pertussis intracerebral challenge model
(11). Here we show that unlike BALB/c (H-2d) mice
which reproducibly clear a respiratory challenge within 40
d (9), C57BL/6 and 129Sv/Ev (both H-2b) do not com-
pletely clear a respiratory challenge until up to 100 d after
challenge (Fig. 3).
Figure 1. Survival of IFN-gR2/2 mice after B. pertussis challenge. In
one experiment groups of 24 IFN-gR2/2 (s) or 24 wild-type 129Sv/Ev
(u) mice were aerosol challenged with B. pertussis which resulted in an
inoculum of 6 3 104 CFU/lung, determined from a sample group killed
2 h after challenge. In a separate experiment 6 IFN-gR2/2 mice (d) re-
ceived a higher dose challenge, which resulted in 1 3 106 CFU/lung 2 h
after challenge. Six wild-type 129Sv/Ev mice (j) exposed to the higher
dose of bacteria all survived the challenge (displayed offset for clarity).
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Aerosol infection of Ig2/2 mice resulted in a persistent
chronic lung infection and a failure to clear the bacteria
from the lungs (Fig. 3 C). However B cell knockout mice
were not overwhelmed by the infection and survived to
the termination of the experiment 20 wk after challenge.
The pattern of infection was similar to that seen in athymic
nu/nu BALB/c mice (9), thus demonstrating a requirement
for B cells as well as T cells in resolution of B. pertussis res-
piratory infection.
Antibody Responses in B. pertussis-infected Gene Knockout
Mice. The contribution of antigen-specific B cells and
specific Ig to the resolution of B. pertussis infection of hu-
mans and experimental animals is controversial (6–8). The
development of the specific antibody response after aerosol
challenge was characterized in normal mice and in mice
with targeted gene disruptions. The results shown in Table
2 confirm that Ig2/2 mice, which lack mature B cells, fail to
mount an IgG antibody response. In contrast, wild-type
C57BL/6 and 129Sv/Ev mice, as well as the IL-42/2 and
IFN-gR2/2 gene knockout mice develop B. pertussis-spe-
cific serum antibody by day 24 after challenge, which in-
Figure 2. Pathological find-
ings in IFN-gR2/2 mice after
respiratory infection with B. per-
tussis. Mice were challenged
with 2 3 1010 CFU/ml giving 6
3 104 CFU/lung 2 h later. (A)
Liver: aggregates of neutrophils
and macrophages with reactive
changes in adjoining hepatocytes.
(B) Mesentery: macrophages and
neutrophils surround a central
area of necrosis (necrotic pyo-
granuloma). (C) Brain: neutro-
phils, macrophages and fibrin de-
posits in the leptomeninges. (D)
Lung: granular basophilic debris
(arrows) in the alveolar spaces with
macrophage and neutrophil infil-
tration primarily in alveolar walls.
(A–D, hematoxylin and eosin [H
& E] staining) (E) Lung: B. pertussis
antigen in the lumen of alveoli
and a bronchiole (arrow). Anti–B.
pertussis, haematoxylin counter-
stain. (F) Mesentry: intracytoplas-
mic deposits of B. pertussis anti-
gen in macrophages in an area of
pyogranulomatous inflammation.
Anti–B. pertussis, haematoxylin
counterstain. Results are repre-
sentative of 15 mice from two
challenge experiments. Similar
pathological lesions were observed
in tissue from all mice examined,
except for the brain, where lesions
were visible in only 3 out of 7 mice
examined. Original magnifica-
tions: (A, C–F) 3400; (B) 3200.
Table 1. Disseminating B. pertussis infection in IFN-gR2/2 mice
Mice
B. persussis (log10 CFU)
Lungs Blood Liver
IFN-gR2/2 6.6 (0.2) 3.0 (2.5) 2.0 (1.3)
129Sv/Ev 5.7 (0.4) 2* 2
Ig2/2 5.8 (0.4) 2 2
C57BL/6 4.9 (0.3) 2 2
B. pertussis colony counts recovered from lungs (CFU/lung) and whole
blood (CFU/ml) 10 d after challenge and from liver (CFU/liver) 24 d
after aerosol challenge with 2 3 1010 CFU/ml B. pertussis (time points
reflect peak bacterial recovery from tissue, detectable in the blood of in-
fected IFN-gR2/2 from days 3–11 and in the liver from days 7–56 after
challenge). Results are mean (SE) values for 4 mice tested individually
in triplicate and are representative of two experiments. The lower de-
tection limit was 0.5 log10 CFU per organ or per ml blood.
*Undetectable bacteria.
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creases in titer until at least day 100. Higher antibody titers
were observed early after infection in IFN-gR2/2 mice,
when compared with the wild-type strain. Conversely IL-
42/2 mice produced lower titers of specific antibody than
that observed in wild-type C57BL/6 mice at early time
points. An examination of the antibody isotypes revealed
that the predominant IgG subclass detected was IgG2a,
with little or no IgG1, except in IFN-gR2/2 mice which
displayed higher titers of IgG2b and lower levels of IgG2a
(Fig. 4). This pattern was consistent between analyses on
serum samples recovered 24, 43, and 100 d after challenge.
Cell-mediated Immune Responses in B. pertussis-infected Gene
Knockout Mice. The development of systemic cell-medi-
ated immune responses in B. pertussis infected animals is
thought to be central to clearance of the bacteria from the
lungs (9–11). Positive spleen cell proliferative responses to
heat killed B. pertussis could be detected in gene knockout
and wild-type mice at day 14 after aerosol challenge (data not
shown). Although relatively high background responses were
observed with medium alone, this has previously been re-
ported during B. pertussis infection of mice and children
(21, 22) and may reflect activation of cells in vivo. The
proliferative response to the putative protective antigens
showed some variation; responses to PT were strongest in
IFN-gR2/2 mice and were detectable in this group from
Figure 3. Course of B. pertussis respiratory infection in normal and
gene knockout mice. IL-42/2 and C57BL/6 (A), IFN-gR2/2 and 129Sv/Ev
(B), and Ig2/2 and C57BL/6 (C) mice were infected by aerosol with 2 3
1010 CFU/ml B. pertussis, giving an initial colonization of 2–8 3 104 per
lung. Groups of mice were killed at intervals after challenge and the num-
ber of viable bacteria estimated by performing colony counts on individ-
ual lung homogenates. Results are representative from two experiments
and are presented as mean (6SE) CFU in the lungs estimated for three or
four mice at each time point.
Figure 4. Subclass of B. pertussis–specific IgG in the serum 43 d after
respiratory infection of wildtype and gene disrupted mice. Serum IgG was
measured by B. pertussis–specific ELISA. Results are given as the geomet-
ric mean (6SE) ELISA titers from at least four mice determined in qua-
druplicate.
Table 2. Bordetella Pertussis-specific Serum IgG Responses after 
Respiratory Infection of Mice with Targeted Gene Disruptions
Days after
challenge
Antibody titer*
129Sv/Ev IFN-gR2/2 C57BL/6 IL-42/2 Ig2/2
7 2‡ 2 2 2 2
14 2 1.7 (0.1) 1.7 (0.1) 2 2
24 2.0 (0.1) 2.5 (0.1) 3.0 (0.1) 2.0 (0.1) 2
43 2.7 (0.2) 3.0 (0.1) 3.7 (0.1) 3.5 (0.4) 2
100 .4.0 .4.0 .4.0 .4.0 2
*Groups of gene knockout and wild-type mice were exposed to an
aerosol challenge of virulent B. pertussis and the serum anti–B. pertussis
IgG titers determined by ELISA. Results are shown for 20 mice per
group from 2 experiments and are expressed as the recipocal of the
mean (6SE) antibody titer (log10) for at least 4 mice at each time point
after challenge.
‡Denotes an antibody titer ,1/10.
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day 14, but were detectable in all animals by day 43 (Fig. 5 A).
Unlike the C57BL/6 wild-type mice, responses to FHA
could not be detected in IL-42/2 mice until 24 d after chal-
lenge. Responses to pertactin could not be detected from
any mice before day 24. The B. pertussis-specific prolifera-
tive responses of Ig2/2 mice were compromised compared
with the wild-type C57BL/6 strain. Proliferative responses
to B. pertussis and component antigens were detected on
day 43 (Fig. 5 A), but this had declined by day 100 and
positive proliferative responses could only be detected in
Ig2/2 mice at time points beyond 100 d against whole bac-
terial preparations at high concentrations. Responses to the
putative protective antigens PT, FHA and pertactin could
not be restored by the addition of MHC-matched APC to
the cultures (data not shown).
An examination of the pattern of cytokines induced by
B. pertussis infection of gene knockout mice and their con-
trols revealed that spleen cell preparations from all mice se-
creted IL-2 in an antigen-specific manner by day 14, and
this response was generally strongest at day 43 after chal-
lenge (Fig. 5 B). Levels of IL-2 remained high 100 d after
infection in all except Ig2/2 mice. The production of IFN-g
by spleen cells from infected animals was low at day 14 af-
ter challenge. However by day 24 and beyond antigen-spe-
cific IFN-g production could be detected in all mice (Fig.
5 C). The reason for the lower level of IFN-g production
by spleen cells from IFN-gR2/2 mice compared with the
wild-type strain is not clear, but may reflect a lack of posi-
tive feedback on Th1 cells and negative regulation on the
Th2 population. There was no evidence of bacterial out-
growth from spleen cell cultures derived from infected
IFN-gR2/2 mice and IFN-g could not be detected from
unstimulated control cultures of these cells (Fig. 5 C).
The Ig2/2 strain showed less robust IFN-g production
with appreciable levels only reached by day 43, and only in
response to whole bacteria and not the component bacte-
rial antigens tested. The levels of the Th2 cytokine IL-4
were also tested, but as previously reported (9) no signifi-
cant IL-4 was detected after a single in vitro stimulation of
bulk spleen preparations (data not shown). In contrast, the
Th2 cytokine IL-5 was detected in the supernatant of anti-
gen-stimulated spleen cells from B. pertussis infected IFN-
gR2/2 mice, but not from the wild-type or other strains
examined.
Discussion
The results of this study provide direct evidence of an
obligatory role for B cells and IFN-g in the protective im-
mune response against B. pertussis. Using a murine respira-
tory infection model and mice with disruptions targeted to
the genes for IL-4, the IFN-g receptor, or for the immu-
noglobulin m-chain (B cell knockouts) we demonstrate atypi-
cal disease resulting from disseminating infection in the
absence of functional IFN-g and a persistent infection, con-
fined to the lungs, in the absence of antibody and B cells.
We have previously shown that effective immunization
against B. pertussis respiratory infection in mice is depen-
dent on the induction of cell mediated immunity (9–11).
Respiratory challenge of athymic (nu/nu) BALB/c mice re-
sults in a persistent infection demonstrating an essential role
for T cells in the clearance of a primary infection (9). Fur-
thermore, adoptive transfer studies have shown that MHC
class II–restricted CD41 cells but not CD81 T cells medi-
ate protection against subsequent infection (9). These stud-
ies suggested a role for Th1 cells in protective immunity
against B. pertussis, but interestingly also suggested that
primed B cells and macrophages contribute to effective
bacterial elimination. The present study demonstrates an
essential role for B cells in bacterial clearance, with Ig2/2
Figure 5. Cell mediated im-
mune responses induced after B.
pertussis infection of normal and
gene disrupted mice. Prolifera-
tion (A), IL-2 (B), IFN-g (C),
and IL-5 (D) secretion by spleen
cells from gene disrupted (IFN-
gR2/2, IL-42/2, and Ig2/2) and
wild-type (129Sv/Ev and
C57BL/6) mice examined 43 d
after challenge. Spleen cells (2 3
106/ml) were incubated with
heat-killed whole B. pertussis, 1
3 106 cells/ml (open bar), inacti-
vated PT 5.0 mg/ml (solid bar),
FHA (hatched bar) 5.0 mg/ml, or
pertactin 5.0 mg/ml (horizontal
shading). Results are the mean
responses for 4 mice per group
assayed individually in triplicate.
Proliferative responses are ex-
pressed as CPM (6SE) after sub-
traction of background re-
sponses to medium alone, which
ranged from 5,000–10,000 cpm.
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mice failing to clear a respiratory challenge, and indicates
that both CD41 T cells and B cells are required for com-
plete elimination of B. pertussis from the lungs. It is not
clear which aspect of B cell function is central to the pro-
tective mechanism. The T cell proliferative and cytokine
responses against B. pertussis and in particular against the
soluble bacterial components are less robust than in wild-
type control mice, however these responses are detectable
but do not correspond with a decline in bacterial load.
These findings suggest that while defective antigen presen-
tation to T cells may contribute to the lack of clearance in
Ig2/2 mice, failure to mount an antibody response may also
contribute to bacterial persistence. Virulent B. pertussis is
also known to exhibit varying degrees of resistance to the
classical complement pathway of lysis by virtue of the re-
cently described products of the brk locus (23). Taken to-
gether these data suggest that the lack of specific opsonizing
antibody may render Ig2/2 mice unable to clear the bacte-
rium. It should also be noted that bacterial numbers in the
lungs of B cell knockout mice increase and then plateau at
day 21. The observation that these mice are not over-
whelmed by infection but survive beyond 100 d after chal-
lenge strongly supports a role for other nonhumoral im-
mune mechanisms in limiting pulmonary infection.
The demonstration of B. pertussis in the liver and the
early bacteremia, together with the pathological changes in
the liver and other organs of aerosol infected IFN-gR2/2
mice indicate an important role for IFN-g in the strict lo-
calization of B. pertussis infection to the lungs of immuno-
competent animals. Although the full significance of the
brain pathology observed in certain IFN-gR2/2 mice is not
clear, cases of encephalitis have been associated with whoop-
ing cough in children (24). The probable hematogenic dis-
semination of B. pertussis in the absence of functional IFN-g
may be of significance to the reported isolation of B. pertus-
sis from blood culture of a patient with Wegener’s granulo-
matosis (25), and the ability of B. holmesii, B. hinzii, and B.
bronchiseptica to cause bacteremia or sepsis (26–28). The re-
duced ability of the immature immune system to secrete
IFN-g and other cytokines may explain the greater suscep-
tibility of human infants and neonatal mice to B. pertussis
infection. Although neonatal mice were not examined in
the present study, the results of preliminary experiments did
demonstrate that in comparison with adult mice, younger
IFN-gR2/2 mice were more susceptible to the lethal ef-
fects of bacterial dissemination.
Interestingly viable virulent bacteria were isolated from
the livers of IFN-gR2/2 mice early after infection and im-
munohistochemical analysis of mesenteric lymph nodes dem-
onstrated intracytoplasmic bacterial aggregates within mac-
rophages. We found evidence of disseminating infection in
IFN-gR2/2 mice before the development of B. pertussis-
specific antibody or T cell responses in wild-type or knock-
out mice. This suggests that IFN-g produced by cells of the
nonadaptive immune response such as NK cells or gdT cells
plays an important role in containing B. pertussis to the lung
during the initial period of infection, perhaps through the
killing of bacteria exploiting an intracellular niche within
macrophages (29). Atypical disease has previously been re-
ported in disease models of obligate and facultative intracel-
lular bacteria using gene knockout mice. Experimental L.
monocytogenes infection of TCR d2/2 mice results in large
abscess-like liver lesions not seen in normal control mice
(30), and disseminated tuberculosis is observed in IFN-g
gene disrupted mice infected either intravenously or aero-
genically (31), highlighting the key role of IFN-g in an-
other important respiratory disease.
Whole B. pertussis and its components are known to
elicit NO production by murine macrophages under a vari-
ety of conditions (32, 33). It has been reported that IFN-g
can augment bacterial killing and NO production by B.
pertussis infected macrophages in vitro (28, 32). Further-
more, IFN-gR2/2 mice have an impaired ability to pro-
duce reactive nitrogen intermediates (34, 35 and unpub-
lished observations). Taken together with the findings of
the present study, these observations suggest that NO or
reactive nitrogen intermediates may play a role in the de-
struction of an intracellular reservoir of B. pertussis and the
prevention of disseminated disease. However IFN-gR2/2
mice show unimpaired bacterial clearance from the lungs
suggesting that this is not an essential mechanism of pulmo-
nary elimination during B. pertussis infection and that
TNF-a, TNF-b, or Th2 derived cytokines may compen-
sate for certain of the functions of IFN-g in immunity to
B. pertussis in the knockout animals.
It has been suggested that both Th1 and Th2 cells must
interact for optimal mucosal protection against B. pertussis
(36). Our demonstration of similar kinetics of bacterial clear-
ance from the lungs of IFN-gR2/2 or IL-42/2 and wild-type
mice demonstrates that there is a degree of redundancy in
the cytokines or the Th subpopulations that mediate bac-
terial elimination from the lungs. However, IFN-g, whether
T cell derived or from other cell types, appears necessary to
contain infection within the lungs. It is likely that the early
production of IFN-g by cells of the innate immune system
in response to B. pertussis infection favors the subsequent
induction of a Th1 type response. This may explain the
high level of protection observed in convalescent mice or
in animals immunized with pertussis vaccines formulated
with IL-12 or with vaccines which include components
that induce endogenous IL-12 production (19). Thus IFN-g
may function to activate the antimicrobial activity of mac-
rophages against an intracellular reservoir of bacteria. How-
ever this does not exclude the obvious role for CD41 T
cells in providing help for antibody responses of a function-
ally relevant isotype (37). Our demonstration of reduced
levels of B. pertussis–specific IgG2a in infected IFN-gR2/2
mice compared with the wild-type strain is consistent with
the latter possibility.
Our findings may also provide an explanation for the
failure to demonstrate a serological correlate of protection
induced with acellular pertussis vaccines, that have recently
been shown to confer a high level of protection against dis-
ease in children. (38, 39). These vaccines induce potent,
but short lived antibody responses (38, 39) and B. pertussis-
specific T cells with a Th0 or mixed Th1/Th2 cytokine
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profile (22). We have previously shown that infection pref-
erentially induces Th1 cells and that these cells appear to
play a critical role in protection against B. pertussis (9, 21).
In the present study, the production of Th2 cytokines and
the lack of functional IFN-g did not affect the clearance of
bacteria from the lung during a primary B. pertussis infec-
tion, but did result in dissemination of this bacterium. In
conclusion, our findings support a model of bacterial clear-
ance from the respiratory tract which requires both B cells
and CD41 T cells to resolve infection and indicate that
functional IFN-g plays an essential role in confining B. per-
tussis to the mucosal site of the lung.
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